PFDSELECT MEDICAL RECEIVABLE 1009 Amends Exempt Offering Filing

TL;DR

**PFDSELECT MEDICAL RECEIVABLE 1009 just amended their exempt securities offering, so keep an eye on their funding.**

AI Summary

PFDSELECT MEDICAL RECEIVABLE 1009, LLC filed an amended Form D/A on March 25, 2026, updating a previous notice of an exempt offering of securities. This filing, identified by SEC Accession No. 0002004353-26-000003, indicates a change or correction to a prior filing regarding their capital raising activities. For investors, this matters because it provides updated information on how the company is funding its operations, which can impact its financial health and future growth prospects.

Why It Matters

This amendment provides updated details on PFDSELECT MEDICAL RECEIVABLE 1009, LLC's exempt securities offering, which is crucial for understanding their financing structure and potential dilution or capital infusion.

Risk Assessment

Risk Level: low — An amended filing (D/A) typically corrects or updates previous information, which is a standard administrative process and not inherently high-risk.

Analyst Insight

An investor should review the original Form D filing that this D/A amends to understand the full scope of the exempt offering and then analyze the specific changes introduced by this amendment to assess any impact on the company's capital structure or investor rights.

Key Numbers

• 0002004353-26-000003 — SEC Accession No. (unique identifier for this specific filing)
• 2026-03-25 — Filing Date (the date the D/A form was filed with the SEC)
• 2026-03-24 — Accepted Date (the date the filing was accepted by the SEC)
• 021-508999 — File No. (the SEC file number associated with the offering)
• 26788214 — Film No. (the SEC film number for the filing)

Key Players & Entities

• PFDSELECT MEDICAL RECEIVABLE 1009, LLC (company) — the filer of the D/A form
• 0002004353 (company) — the CIK (Central Index Key) for the filer
• 934663995 (company) — the EIN (Employer Identification Number) for the filer
• NV (company) — the State of Incorporation for the filer
• 2026-03-25 (date) — the filing date and effectiveness date of the D/A form

Forward-Looking Statements

• PFDSELECT MEDICAL RECEIVABLE 1009, LLC will likely continue to update its exempt offering details if further changes occur. (PFDSELECT MEDICAL RECEIVABLE 1009, LLC) — high confidence, target: 2027-03-25

FAQ

Key Financial Figures

• $1 — enues   No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,
• $1,000,000 — No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,
• $5,000,000 — Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001
• $1,000,001 — e   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000
• $5,000,001 — $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000
• $25,000,000 — $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000   $25,000,001
• $25,000,001 — $25,000,000 $5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,0
• $50,000,000 — 5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,0
• $100,000,000 — 25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $1
• $50,000,001 — 0,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $100,000,000   O

Filing Documents

• primary_doc.html (D/A)
• primary_doc.xml (D/A) — 8KB
• 0002004353-26-000003.txt ( ) — 9KB

From the Filing

Form D FORM D Notice of Exempt Offering of Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. OMB APPROVAL OMB Number: 3235-0076 Estimated Average burden hours per response: 4.0 1. Issuer's Identity CIK (Filer ID Number) Previous Name(s) None Entity Type Corporation Limited Partnership   Limited Liability Company   General Partnership   Business Trust Other   Name of Issuer   PFDSELECT MEDICAL RECEIVABLE 1009, LLC Jurisdiction of Incorporation/Organization NEVADA   Year of Incorporation/Organization Over Five Years Ago Within Last Five Years (Specify Year) 2023 Yet to Be Formed           2. Principal Place of Business and Contact Information Name of Issuer   PFDSELECT MEDICAL RECEIVABLE 1009, LLC Street Address 1 Street Address 2   11500 S. EASTERN AVE., SUITE#150     HENDERSON   NEVADA     89052   888 475 4748   3. Related Persons Last Name First Name Middle Name Pryke Robert E. Street Address 1 Street Address 2   6430 Oak Canyon- Suite 150       Irvine   CALIFORNIA   92618   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Robert E. Pryke is an Executive Officer of PFD Capital Partners, Inc., a Nevada corporation, which is the Manager of the Issuer. Last Name First Name Middle Name Ermoian Gary L Street Address 1 Street Address 2   429 13th Street       Modesto   CALIFORNIA   95354   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Gary L.Ermoian is an Executive Officer and Director of PFD Capital Partners, Inc., a Nevada corporation, which is the Manager of the Issuer. Last Name First Name Middle Name Hansen Eric E. Street Address 1 Street Address 2   6430 Oak Canyon, Suite 150       Irvine   CALIFORNIA   92618   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Eric Hansen is an Executive Officer of PFD Capital Partners, Inc., a Nevada corporation, which is the Manager of the Issuer. 4. Industry Group   Agriculture Banking & Financial Services     Commercial Banking     Insurance   Investing     Investment Banking     Pooled Investment Fund   Other Banking & Financial Services   Business Services Energy     Coal Mining     Electric Utilities     Energy Conservation     Environmental Services     Oil & Gas     Other Energy Health Care     Biotechnology     Health Insurance     Hospitals & Physicians     Pharmaceuticals     Other Health Care                         Manufacturing Real Estate   Commercial   Construction   REITS & Finance   Residential Other Real Estate   Retailing Restaurants Technology   Computers   Telecommunications   Other Technology Travel   Airlines & Airports   Lodging & Conventions   Tourism & Travel Services   Other Travel Other        5. Issuer Size Revenue Range Aggregate Net Asset Value Range No Revenues   No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $100,000,000   Over $100,000,000   Decline to Disclose   Decline to Disclose   Not Applicable   Not Applicable   6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply) Rule 504(b)(1) (not (i), (ii) or (iii)) Rule 506(b)         Rule 504 (b)(1)(i) Rule 506(c) Rule 504 (b)(1)(ii) Securities Act Section 4(a)(5) Rule 504 (b)(1)(iii) Investment Company Act Section 3(c)     7. Type of Filing   New Notice Date of First Sale   2024-04-02   First Sale Yet to Occur   Amendment     8. Duration of Offering Does the Issuer intend this offering to last more than one year?   Yes   No     9. Type(s) of Securities Offered (select all that apply) Pooled Investment Fund Interests Equity Tenant-in-Common Securities Debt Mineral Property Securities Option, Warrant or Other Right to Acquire Another Security Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security Other (describe)       10. Business Combination Transaction Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?   Yes   No Clarification of Response (if Necessary)       11. Minimum Investment Minimum investment accepted from any outside investor $   10000 USD 12. Sales Compensation Recipient   Recipient CRD Number None   OpenDeal Broker, LLC   297797 (Associated) Broker or Dealer None (Associated) Broker or Dealer CRD Number None   OpenDeal Broker, LLC   297797 Street Address 1       Street Address 2 149 5th Avenue     New York   NEW YORK   10010   13. Offering and Sales Amounts   Total Offering Amount $ 19000000 USD Indefinite Total Amount Sold $ 18080329 USD Total Remaining to be Sold $ 919671

View Full Filing

View this D/A filing on SEC EDGAR